跳至主要内容
临床试验/NCT06038331
NCT06038331招募中2 期

Evaluation of the Treatment of Symptomatic Scaphotrapeziotrapezoidal (STT) Osteoarthritis With a Treated, Devitalized and Sterile Amniotic Membrane of Umbilical Cord Placed in Joint Interposition

TBF Genie Tissulaire4 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2024年5月28日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
14
试验地点
4
主要终点
Decrease of the symptomatology related to the STT OA

研究概览

简要总结

The aim of this open, prospective, multicenter trial is to evaluate the use of a sterile, devitalized, processed umbilical cord amniotic membrane implant placed in joint interposition in the treatment of STT osteoarthritis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female; age between 18 and 75 years.
  • Patient with symptomatic STT OA.
  • Patient treated medically for functional signs for more than 3 months, without improvement, justifying a surgical intervention.
  • Patient with a QuickDash score > 33 points (converted to 50%).
  • Patient with wrist pain in front of the STT joint at rest = or > 4/10 on VAS.
  • Patient who received the study information and provided consent.
  • Member or beneficiary of a national health insurance plan.

排除标准

  • Pregnant or breastfeeding woman; woman without effective contraception.
  • Patient with functional rhizarthrosis that has not been stabilized or treated medically or surgically.
  • Patient with signs of neuropathy with functional disorders such as hyperesthesia.
  • Patient with uncontrolled epilepsy or neuropathy that contraindicates locoregional anesthesia.
  • Person confined by a judicial or administrative decision.
  • Adult subjected to legal protection measures or unable to provide his/her consent.

研究组 & 干预措施

SclerFIX-IP

Experimental

Treated, devitalised and sterile graft of umbilical cord amniotic membrane

干预措施: SclerFIX-IP (Biological)

结局指标

主要结局

Decrease of the symptomatology related to the STT OA

时间窗: 12 months

Quality of life related to STT OA evaluated using Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire (0 = no disability, 100 = most severe disability); a decrease of 25% of the score is expected between subject's inclusion and the 12-month postoperative visit

次要结局

  • Improvement of functional activities involving the thumb(1 month, 3 months, 6 months, 12 months)
  • No apparent joint space anomaly(12 months)
  • Increase of thumb strength(3 months, 6 months, 12 months)
  • Decrease of pain related to STT OA(1 month, 3 months, 6 months, 12 months)
  • Absence of inflammatory reactions and good local tolerance of the implant(Through study completion (12 months))
  • Increase of grip strength(3 months, 6 months, 12 months)

研究者

发起方
TBF Genie Tissulaire
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验